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Abstract
Integrated constraint-based metabolic and regulatory models can accurately predict cellular growth phenotypes arising
from genetic and environmental perturbations. Challenges in constructing such models involve the limited availability of
information about transcription factor—gene target interactions and computational methods to quickly refine models
based on additional datasets. In this study, we developed an algorithm, GeneForce, to identify incorrect regulatory rules and
gene-protein-reaction associations in integrated metabolic and regulatory models. We applied the algorithm to refine
integrated models of Escherichia coli and Salmonella typhimurium, and experimentally validated some of the algorithm’s
suggested refinements. The adjusted E. coli model showed improved accuracy (,80.0%) for predicting growth phenotypes
for 50,557 cases (knockout mutants tested for growth in different environmental conditions). In addition to identifying
needed model corrections, the algorithm was used to identify native E. coli genes that, if over-expressed, would allow E. coli
to grow in new environments. We envision that this approach will enable the rapid development and assessment of
genome-scale metabolic and regulatory network models for less characterized organisms, as such models can be
constructed from genome annotations and cis-regulatory network predictions.
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Introduction
A current challenge in systems biology is reconstructing
transcriptional regulatory networks from experimental data (e.g.
gene expression, genome sequence, and DNA-protein interaction),
due to the complexity of interactions in these networks and the
limited information on network components and interactions for
most organisms [1,2]. Even for well-studied model organisms, such
as E. coli and Saccharomyces cerevisiae, inferred or indirect regulatory
interactions have to be included in genome-scale transcriptional
regulatory reconstructions due to existing knowledge gaps in how
genes are transcriptionally regulated [3,4]. Reconstructed regula-
tory networks will be incomplete, reflecting incomplete knowledge
about cis-regulatory networks, and may include incorrect interac-
tions. As such, methods for iterative validation and refinement of
regulatory reconstructions are needed in order to assess new
experimental datasets as they emerge [5,6]. Such approaches need
to identify and eliminate inconsistencies between the reconstructed
network and new experimental data, and to include newly
discovered network interactions [3]. However, identifying the
cause of inconsistencies in a highly interconnected network using
manual efforts is not a trivial task, and can be labor intensive
particularly for genome–scale transcriptional regulatory network
models. Therefore, systematic approaches that automate this
iterative procedure are useful for identifying new or incorrect
connections in biological models; such approaches have been
developed for analysis and correction of metabolic networks [7–9].
In this paper, we present an approach that allows for the
automated adjustment of an integrated genome-scale metabolic
and transcriptional regulatory network model, by comparing the
emergent properties of the integrated networks to cellular growth
phenotypes. These adjustments result in testable hypotheses about
transcriptional regulation and metabolism in organisms.
While there are many types of regulatory modeling approaches
(reviewed in [10]), Boolean modeling of regulatory interactions
can be beneficial when modeling large-scale regulatory networks
because (i) such formalism requires minimal parametric details to
be incorporated [11], and (ii) these Boolean models can be
integrated with constraint-based metabolic models [3,4]. One of
the commonly used constraint-based modeling approaches for
metabolic models is flux balance analysis (FBA), which predicts an
optimal steady-state flux distribution in a metabolic network [12].
This can be extended to integrated metabolic and regulatory
models, referred to as regulated flux balance analysis (rFBA),
which accounts for transcriptional regulation as well as the other
governing physicochemical constraints [13,14]. While the meta-
bolic and regulatory models in rFBA are solved iteratively, newer
approaches for integrating metabolic and regulatory models allow
the models to be combined into a single model using an mixed-
integer linear programming (MILP) formalism [15]. In this case,
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identify optimal flux distributions that satisfy both models
simultaneously. We have recently developed an efficient SR-FBA
formulation that systematically integrates transcriptional regulato-
ry and metabolic networks [16] which was used here.
In this work, we developed an algorithm (called GeneForce) to
reconcile integrated regulatory and metabolic model predictions
with experimental data, by automatically identifying and overrid-
ing transcriptional regulatory rules that cause inconsistencies
between model predictions and experimental observations. The
approach can be used in cases where both the experimental data
and an un-regulated metabolic model agree on a positive growth
phenotype (cells can grow), but the integrated metabolic and
regulatory model predicts a non-growth phenotype (cells cannot
grow). In these cases, the GeneForce algorithm allows the
integrated metabolic and regulatory model to achieve growth by
violating regulatory rules as needed, while minimizing the total
number of regulatory violations in order to maximally preserve the
original regulatory interactions present in the regulatory network
reconstruction. These rule violations indicate that regulatory rules
describing gene expression are incorrect or that isozymes or
alternative pathways are present in the metabolic network.
We first applied the GeneForce method to refine the genome-
scale transcriptional regulatory network for E. coli, iMC1010
v1 [3]
which was updated here to include newly discovered Lrp
regulatory interactions [17]. The algorithm was used to analyze
a large collection of ,50,000 E. coli knockout mutant growth
phenotypes [18,19], and the suggested regulatory corrections
resulted in a ,1–8% improvement in model accuracy over the
original models, which had already been adjusted during their
initial development to improve model accuracy. In addition to
correcting regulatory rules, we applied the GeneForce algorithm to
predict genes that, if overexpressed or constitutively expressed,
could rescue non-growth phenotypes of E. coli strains (wild-type or
mutants) in certain growth environments. Finally, we applied the
GeneForce method to investigate the conservation of transcriptional
regulatory interactions between E. coli and S. typhimurium. The E.
coli transcriptional regulatory rules were integrated with a
metabolic model for S. typhimurium that included metabolic genes
and reactions from a recent metabolic reconstruction iRR1083
[20]. GeneForce suggested a small set of rule corrections for this
hybrid network model were needed, based on analysis of S.
typhimurium growth phenotyping data, suggesting that regulation
may be highly conserved between these two organisms. While the
approach has been used here to correct Boolean representations of
transcriptional regulation, it could easily be extended to consider
non-Boolean approaches to modeling transcriptional regulation as
they are developed.
Results
Regulatory rule correction algorithm, GeneForce
We developed an automated MILP approach, GeneForce, to
identify problematic Boolean regulatory rules in an integrated
metabolic and transcriptional regulatory model. The method
identifies regulatory rules that prevent the models from predicting
cellular growth in conditions, which are capable of supporting
growth experimentally. The approach can be used when the
integrated metabolic and regulatory model does not predict
growth, but experimental data and metabolic model predictions
(without any regulatory constraints) indicate growth occurs.
The basic idea of the GeneForce algorithm is to allow the
integrated metabolic and regulatory model to violate a minimal set
of transcriptional regulatory rules so that growth can occur in a
particular condition. The algorithm therefore adds an additional
constraint that the model must satisfy a minimal threshold growth
rate. The algorithm uses a set of ‘rule-violation’ equations (see
Supporting Information Text S1 for details) to relax certain
regulatory constraints (by allowing for expression of un-expressed
genes) thus allowing the model to readjust the metabolic and
regulatory model solution space to include solutions with growth
rates exceeding the minimum threshold. The ‘rule violation’
equations, invoked at the gene level, allow the regulatory rules for
metabolic genes to be violated using additional surrogate gene
expression indicators (y9g) that can differ in value from the gene
expression indicators (yg), the latter of which are determined by
Boolean regulatory rules. Normally in the integrated metabolic
and regulatory model a flux is constrained to be zero if the
necessary metabolic genes are determined to be un-expressed
(yg=0). In the GeneForce algorithm, the bounds on the metabolic
fluxes are dependent on y9g instead of yg. The reaction
dependence on y9g then allows the model to override a minimum
number of gene expression indicators (where yg=0 but y9g=1)so
that the threshold growth rate can be achieved.
The example in Figure 1 illustrates how the GeneForce algorithm
uses the rule violation technique to achieve non-zero growth in an
integrated metabolic and regulatory model in agreement with the
metabolic model predictions. As shown in the Figure 1A the
metabolic model predicts positive growth in the presence of Axt,
whereas the integrated metabolic and regulatory model predicts
no growth due to the regulatory interactions between gene G1 and
transcription factor TF1 (Figure 1B). Expression of G1 is needed
for growth since the corresponding enzyme catalyzes an essential
reaction (BRC), but expression of G1 requires TF1 to be active,
and the binding activity of TF1 is inhibited by metabolite A. This
non-growth phenotype is overcome in the GeneForce algorithm by
making the reaction availability dependent on the surrogate
gene expression indicator y9G1, which is not dependent on the
Author Summary
Computational models of biological networks are useful
for explaining experimental observations and predicting
phenotypic behaviors. The construction of genome-scale
metabolic and regulatory models is still a labor-intensive
process, even with the availability of genome sequences
and high-throughput datasets. Since our knowledge about
biological systems is incomplete, these models are
iteratively refined and validated as we discover new
connections in biological networks, and eliminate incon-
sistencies between model predictions and experimental
observations. To enable researchers to quickly determine
what causes discrepancies between observed phenotypes
and model predictions, we developed a new approach
(GeneForce) that automatically corrects integrated meta-
bolic and transcriptional regulatory network models. To
illustrate the utility of the approach, we applied the
developed method to well-curated models of E. coli
metabolism and regulation. We found that the approach
significantly improved the accuracy of phenotype predic-
tions and suggested changes needed to the metabolic
and/or regulatory models. We also used the approach to
identify rescue non-growth phenotypes and to evaluate
the conservation of transcriptional regulatory interactions
between E. coli and S. typhimurium. The developed
approach helps reconcile discrepancies between model
predictions and experimental data by hypothesizing
required network changes, and helps facilitate the
development of new genome-scale models.
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PLoS Computational Biology | www.ploscompbiol.org 2 October 2010 | Volume 6 | Issue 10 | e1000970Figure 1. Example Network Illustrating the GeneForce Approach. (A) Predicted fluxes through an un-regulated metabolic network, where all
reactions are available (indicated by the green arrow) and flux through the biomass reaction (vBiomass) is maximized. The numbers and thickness of
the arrows indicate flux values. (B) Predicted flux through an integrated metabolic and regulatory model (SR-FBA), where numbers and arrow
thicknesses indicate flux values. The regulatory network includes regulation of two genes (G1 and G2) by two transcription factors (TF1 and TF2),
where TF1 activates G1 and TF2 represses G2. G1 is needed for the BRC reaction and G2 is needed for the ARD reaction. Binary gene expression
status (yG1 and yG2) and transcription factor activity (xTF1 and xTF2) indicators show the expression and binding status of G1, G2, TF1 and TF2,
respectively, with value 1 indicating the expressed/active condition and 0 indicating the unexpressed/inactive condition. Regulatory interactions are
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associated reaction is essential for growth (Figure 1C). Since the
flux ranges in GeneForce are directly dependent on y9g rather than
yg, the reaction associated with G1 can carry flux through it
allowing growth to occur, even though the gene is not expressed in
the Boolean model. It should be noted that the other regulatory
rule in the network (yG2 repressed by TF2) was not overruled
(yG29=y G2=0), even though yG29 could also take the value 1
instead of 0. This is because the algorithm minimizes the sum of
the distances between the surrogate and the original gene
expression indicators, (
P
g
y0
g{yg), and hence the number of
regulatory rule violations by the algorithm. Minimization of this
objective function forces the binary vector of y9g to remain as close
as possible to that of yg, thus minimizing the number of rule
violations. This ensures that the original, literature-derived
regulatory rules are maximally conserved and reflected in the
predicted behavior of the integrated metabolic and regulatory
network.
Rule correction by GeneForce: application to an E. coli
regulatory network model
We used the GeneForce algorithm to refine the regulatory rules
in an updated metabolic and regulatory E. coli model based on
iMC104 (the regulatory portion of the integrated iMC1010
v1
model [3]), where we had revised the regulatory rules for genes in
the Lrp regulon based on experimental data [17] (see methods for
details). The Lrp-modified iMC104 model was combined with a
metabolic model and the resulting integrated model was used to
predict growth phenotypes that were compared to experimental
growth phenotypes for a large number of knockout mutants tested
for growth in various conditions [18,19]. The model refinements
were carried out in three successive steps. First, the updated
regulatory rules from iMC104 were integrated with the metabolic
model iJR904 [21] and rule corrections were made to give the first
refined version of the regulatory model iMC105A. Second, the
iMC105A regulatory model was integrated with an updated
metabolic network iAF1260 [22] and adjusted to give the second
refined regulatory model, iMC105AB. Finally, the iMC105AB
regulatory model was further refined using phenotypic data
generated in this study for three global transcription factor
knockout mutants (DarcA, DpurR and Dlrp) to give the final version
of the regulatory model iMC105ABC. Here we consider the
regulatory models (iMC104, iMC105A, iMC105AB, and iM-
C105ABC) to be just the regulatory part of the integrated models
(the number indicates the total number of transcription factors).
Integration of iJR904 with Lrp-modified iMC104 regulatory
rules allowed comparison of 32,050 growth phenotype predictions
to experimental data (Supporting Information Table S1). The
GeneForce algorithm identified genes with possible problematic
regulatory rules in 3,079 out of the 32,050 cases examined, where
each case represents a mutant grown in a different condition.
Alternative optimal solutions exist for only 298 of the 3,079 cases,
where most (281 out of 298) were needed to correct predictions for
growth on L-serine as a nitrogen source or the DsdaB mutant.
These 3,079 cases correspond to cases where a zero growth
prediction by the integrated metabolic and regulatory model
contradicted both the experimental data and the metabolic model
prediction (+/+/2; where + indicates growth and 2 indicates no
growth, and the order corresponds to the results from experiments
/ metabolic model / integrated model). Not all regulatory rules
identified by the algorithm in the 3,079 cases were adjusted, as
they may cause new incorrect predictions in other conditions.
Instead, corrections were made for regulatory rules that were
frequently identified as problematic for a particular knockout
mutant or growth environment (Table 1, refinement step A). In
total, regulatory rules for ten genes (glmU, ilvY, ilvC, sdaC, cycA,
gcvB, dsdX, rpiR, acnA, and ilvA) were corrected in the first
regulatory model refinement, iMC105A. Two gene-protein-
reaction (GPR) associations were also corrected in the metabolic
model for two amino acid transport reactions (L-methionine and
D-serine). These model adjustments led to an ,8% improvement
in the overall accuracy of the integrated model from 73.9% to
81.5% (Table 2 and Figure 2A). Due to the addition of the
transcriptional regulator gcvB, this revised regulatory network
iMC105A contained a total of 105 transcription factors.
The second set of refinements (refinement step B), occurred
when the iJR904 metabolic network was replaced with the
updated metabolic network iAF1260 [22]. The inclusion of the
latest metabolic network allowed integrated model predictions to
be compared against 50,327 growth phenotypes, since more genes
and environments are represented in this larger metabolic network
(Supporting Information Table S2). Using this extended set of
growth phenotypes, the algorithm identified a new set of
problematic regulatory rules in iMC105A, and corrections were
made for eleven additional genes, argD, astCADBE, speA, metH, thrA,
rhaS, and rhaR (Table 1, refinement step B) leading to a second
revision of the regulatory model, iMC105AB. Initial correction of
the regulatory rule for argD fixed 262 errors (+/+/2 changed to +/
+/+) associated with cases where arginine is the nitrogen source,
but also introduced 297 new errors (2/+/2 changed to 2/+/+)
for cases where arginine is the carbon source. To correct these new
errors we subsequently refined the rules for the astCADBE operon
and speA gene, in addition to argD, to reconcile the model with
both arginine conditions. The prediction accuracy of the
integrated metabolic and regulatory model (iAF1260+iMC105A)
was 78.1% before all eleven rule corrections were made, and with
this additional second set of regulatory refinements, the iM-
C105AB model could achieve a slightly higher accuracy, 79.9%
(Table 2 and Figure 2A) and with significantly greater coverage of
the available experimental data (50,327 cases versus 32,050 cases).
In the third set of refinements, the refined regulatory model,
iMC105AB, was tested by comparing predictions to newly
acquired experimental data for three transcription factor knockout
mutants (DarcA, DpurR, and Dlrp). The five transcription factors in
iMC105AB with the most metabolic gene targets are Crp, Fnr,
ArcA, PurR and Lrp. Experimental data was already available for
knockout mutants for two of these transcription factors (Crp and
Fnr), however, growth phenotyping data for DarcA, DpurR, and
Dlrp mutants was not available. Therefore, growth experiments on
phenotype microarrays (Biolog, Hayward, CA) were conducted for
the three mutant strains DarcA, DpurR, and Dlrp. The GeneForce
algorithm identified an additional nine genes needing regulatory
shown as dashed lines, where a normal or blunt arrowhead indicates activation and repression, respectively. The colors indicate the state
(active=green, inactive=red) of transcription factors and metabolic gene expression, or the availability of metabolic reactions (available=green,
unavailable=red). (C) Fluxes and surrogate gene expression indicator values as predicted by the GeneForce approach. The reactions (BRC and ARD)
are now dependent on the surrogate gene expression indicators (y9G1 and y9G2) instead of the expression status of genes G1 and G2 (yG1 and yG2). A
threshold biomass flux (mthreshold) is set as a constraint and the GeneForce algorithm minimizes the sum of the differences between the surrogate
gene expression indicators (shown in c) and the gene expression indicators (shown in b) while satisfying this constraint.
doi:10.1371/journal.pcbi.1000970.g001
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Refinement
Step Gene Original Rule Refined Rule Condition
# Comment
A metINQ (NOT MetJ) GPR correction Gly-Met (N)
Met-Ala (N)
Unknown transporter for
L-methionine (PMID: 4604763)
A glmU (NagC) (ON) N-acetyl-D-glucosamine (C,N)
N-acetyl-D-mannosamine (C,N)
N-acetyl-neuraminic acid (N)
Essential gene (PMID:
8407787)
A ilvY (NOT val-L(e).0 ) (ON) b3773 (ilvY)a ´-acetolactate or a ´-
acetohydroxybutyrate inducer
for ilvY (PMID: 10588699)
A ilvC (ilvY) (ilvY AND NOT (val-L(e).0))
OR (NOT ilvY)
b3773 (ilvY) Constitutive expression of ilvC
in ilvY strain (PMID: 6783625)
A sdaC* (Crp AND (NOT Lrp OR
(leu-L(e).0)))
((Crp AND (NOT Lrp OR
(leu-L(e).0)))) OR
(ser-L(e).0)
L-serine (N) Transporters for ser-L; sdaC
ser-L specific, sstT major, tdcC
anaerobic (PMID: 8026499)
A cycA (NOT Lrp OR (leu-L(e).0)) (NOT GcvB) D-alanine (C,N) No Lrp binding; CycA transporter
for 6 amino acids (PMID: 19118351)
A gcvB (NOT GcvR AND GcvA) D-alanine (C,N) New regulatory small RNA
(PMID: 10972807)
A dsdX GPR correction DsdC or
(DsdC and Crp)
D-serine (C,N) New ser-D transporter (This
study, PMID: 16952954);
regulation (PMID: 7592420)
A rpiR (NOT (rib-D(e).0)) (NOT ((all-D(e).0) OR
(rib-D(e).0)))
b2914 (rpiA) iJR904 requires rpiB for rpiA
strain (PMID: 10559180)
A acnA (SoxS) (ON) b0118 (acnB) Two aconitases
(PMID: 9202458)
A ilvA* (NOT Lrp OR (leu-L(e).0)) (ON) b2797 (sdaB) L-serine/L-threonine deaminases;
SdaA (anaerobic), TdcB (anaerobic),
IlvA (PMID: 13405870, 15155761)
B argD (NOT ArgR) (ON) L-arginine (N) Required for L-lysine biosynthesis
B astABCDE ((NOT(Growth.0) AND RpoS)
OR (NRI_hi AND RpoN)) AND
(NOT Lrp OR (leu-L(e).0))
((NOT(Growth.0) AND RpoS)
OR (NRI_hi AND RpoN))
L-arginine (N) AST pathway for L-arginine
degradation (PMID: 9696779)
B speA (NOT (PurR)) (NOT (PurR)) AND (NOT
(AGMT.0))
L-arginine (C) Putrescine inhibits transcription
of speA (PMID: 1646785)
B metH* (MetR) (metR) OR (met-L(e).0) Gly-Met (N)
Met-Ala (N)
methionine represses metE, but
not metH (PMID: 16622061)
B thrA (NOT (thr-L(e).0 OR ile-L(e).0))
AND (NOT Lrp OR (leu-L(e).0))
(NOT (thr-L(e).0O R
ile-L(e).0))
Gly-Met (N)
Met-Ala (N)
methionine represses metL, but
not thrA (PMID: 3910040)
B rhaS (RhaR) (RhaR OR (RhaR AND Crp)) L-lyxose (C) rhaA, rhaT ,- RhaS ,- RhaR
/emph> (PMID: 8757746)
B rhaR (rmn(e).0) (rmn(e).0 OR lyx(e).0
OR man(e))
L-lyxose (C) RhaR ,- rhamnose, lyxose,
mannose (PMID: 8757746)
C serC (Lrp AND NOT (leu-L(e).0)
OR (NOT (Crp)))
(ON) b0889 (lrp) Essential in glucose and glycerol
minimal medium (PMID: 17012394)
C aroA (Lrp AND NOT (leu-L(e).0)) (ON) b0889 (lrp) Essential in glucose and glycerol
minimal medium (PMID: 17012394)
C leuD (NOT(leu-L(e).0) AND Lrp) (NOT(leu-L(e).0) b0889 (lrp) Essential in glucose and glycerol
minimal medium (PMID: 17012394)
C leuC (NOT(leu-L(e).0) AND Lrp) (NOT(leu-L(e).0) b0889 (lrp) Essential in glucose and glycerol
minimal medium (PMID: 17012394)
C leuB (NOT(leu-L(e).0) AND Lrp) (NOT(leu-L(e).0) b0889 (lrp) Essential in glucose and glycerol
minimal medium (PMID: 17012394)
C leuA (NOT(leu-L(e).0) AND Lrp) (NOT(leu-L(e).0) b0889 (lrp) Essential in glucose and glycerol
minimal medium (PMID: 17012394)
C ilvB* (NOT(leu-L(e).0O R
val-L(e).0) AND Crp) to (ON)
(ON) b0889 (lrp)
glucose (C)
gluconate (C)
ilvB required in glucose
condition (this study)
C ilvN* (NOT(leu-L(e).0O R
val-L(e).0) AND Crp) to (ON)
(ON) b0889 (lrp)
glucose (C)
gluconate (C)
regulatory subunit of ilvBN
encoded enzyme complex (PMID:
1512191)
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incorrect phenotype predictions for the Dlrp mutant (Supporting
Information Table S3). Incorporation of these Lrp specific
corrections led to the final refined version iMC105ABC, which
resulted in a small overall improvement (0.01%) in model accuracy
over the previous version iMC105AB (Table 2 and Figure 2A)
when evaluating all data, but a large improvement for the new
phenotype measurements of the three transcription factor deletion
mutants (81.7% accuracy using iMC105ABC vs. 66.1% using
iMC105AB for Dlrp, DpurR, and DarcA phenotypes).
For each +/+/2 case the minimum number of genes whose
regulatory rules had been violated by the GeneForce algorithm was
determined. The distribution of the number of rule corrections
needed for the +/+/2 cases is shown for the first two refinement
steps in Figure 3 before and after the model adjustments were
made (listed in Table 1). The results show that in most cases a
single regulatory rule was preventing the integrated model from
making the correct prediction. The first set of refinements
eliminated most of the +/+/2 cases (Figure 3A), leaving fewer
genes needing rule corrections in the subsequent steps (Figure 3B),
even though more experimental data (50,557 versus 32,050) could
be compared to model predictions.
Alternative optimal solutions were generated for each refine-
ment step by adding integer-cut constraints and re-solving the
GeneForce problem. The number of +/+/2 cases for which
alternative optimal solutions exist can be found in Supporting
Information Table S4. In most cases, they were specific to a
particular knockout mutant or growth environment, and the
alternative optimal solutions were two or three isozymes catalyzing
an essential reaction. For some instances we were able to find
enough information in the literature to determine the most likely
isozymes involved (ilvA, metH, sdaC and thrA). For other cases
described below (dctA, rpiB, and ilvBN), we performed additional
growth phenotyping experiments to determine the final set of
corrections. Overall application of the GeneForce algorithm to
correct +/+/2 cases led to (i) changes in the regulatory rules for
metabolic genes (e.g. glmU, ilvBN, and dctA) (ii) changes in the rules
for TF activities (e.g. RpiR), or (iii) changes in the gene-protein-
reaction (GPR) associations in the metabolic network (e.g. dsdX).
Some examples from the different types of changes are presented
below, and in some cases additional mutant phenotypes were
screened by experiments to confirm the necessary model changes
identified by GeneForce.
In our analysis, the regulatory rule describing the regulation of
glmU by the NagC transcription factor was identified as the most
problematic rule, causing approximately one third of the total
incorrect zero growth predictions by the Lrp-modified iM-
C104+iJR904 integrated model. GeneForce identified the regula-
tory rule for glmU gene as needing a correction for most mutants
grown in conditions where any of the three amino sugars, N-
acetylglucosamine (GlcNAc), N-acetylneuraminate, and N-acet-
ylmannosamine were present. GlmU catalyzes two consecutive
reactions producing an essential precursor UDP-N-acetyl-glucos-
amine (UDP-GlcNAc) for the cell wall of E. coli [23,24]. This gene
has been found to be essential in E. coli [25], supporting
GeneForce’s prediction that the regulatory rule for glmU is
incorrect.
The following two regulatory rules in iMC104 precluded the
gene from being expressed in the integrated model under certain
conditions: ‘NagC is active if NOT (GlcNAc OR glucosamine-6-
phosphate)’ and ‘glmU is expressed if NagC is active’. The first rule
prohibited NagC from being active in the presence of any of the
three amino sugars because glucosamine-6-phosphate is a
common intermediate in their degradation pathways. The
inactivity of NagC subsequently prohibited the expression of glmU
in the integrated model, resulting in a non-growth phenotype
prediction. GeneForce violated the glmU regulatory rule so that
GlmU can carry out the two essential reactions. Although the
Refinement
Step Gene Original Rule Refined Rule Condition
# Comment
C dctA* (((‘‘CRP noMAN’’) AND NOT(ArcA)
AND (DcuR))
(ON) b0889 (lrp)
L-malate (C)
dctA deletion causes prolonged
lag phase (this study)
*indicates alternative optimal solutions exist for this change.
#(C) indicates carbon source and (N) indicates nitrogen source.
A- Rule corrections needed for iMC104+iJR904.
B- Rule corrections needed for iMC105A+iAF1260.
C- Rule corrections needed for iMC105AB+iAF1260.
doi:10.1371/journal.pcbi.1000970.t001
Table 1. Cont.
Table 2. Accuracy and number of rule correction and rescue non-growth cases at successive stages of regulatory rule refinements.
Metabolic network
a iJR904 iJR904 iAF1260 iAF1260 iAF1260
Regulatory network
b iMC104 iMC105A iMC105A iMC105AB iMC105ABC
Total comparisons
c 32,050 32,050 50,327 50,557 50,557
Rule correction cases (+/+/2) 3,079 445 1,546 565 510
Rescue cases (2/+/2) 2,041 1,847 2,130 2,087 2,070
Integrated model accuracy
d 23,670 (73.9%) 26,112 (81.5%) 39,288 (78.1%) 40,403 (79.9%) 40,441 (80.0%)
a,bMetabolic and regulatory networks used in the integrated models.
cTotal number of growth phenotypes analyzed.
dNumber (percent) of cases where the integrated model predictions were in agreement with experimental data.
doi:10.1371/journal.pcbi.1000970.t002
GeneForce: An Approach for Refining Network Models
PLoS Computational Biology | www.ploscompbiol.org 6 October 2010 | Volume 6 | Issue 10 | e1000970regulatory rules shown above were in agreement with experimen-
tal data reported in the literature, the Boolean representation of
the regulatory interaction was too stringent in the model. The
glmU gene contains two upstream promoters P1 and P2, and the
transcription factor NagC is shown to induce expression using the
promoter P1 in the absence of any of the three amino sugars [26].
However, the second glmU promoter, P2, is weakly induced in
presence of N-acetylglucosamine, suggesting that the activating
role of NagC could be dispensable for this promoter [26]. This
suggests that the expression of glmU is not completely abolished
when NagC is inactive, and that the low level of induction at P2 is
still sufficient to allow for the production of UDP-GlcNAc. Since
glmU is required for growth in other environments as well, it is
always expressed in the refined set of regulatory rules.
The integrated model made incorrect predictions for the Dlrp
mutant in a few different conditions, including growth on glucose,
gluconate, and L-malate as sole carbon sources. For the glucose
and gluconate conditions, GeneForce found that either ilvHI or
ilvBN needed to be expressed since these two isozymes are used for
the synthesis of branched chain amino acids. To evaluate which of
these isozymes is used by the cells, we screened a number of Lrp
double mutants for growth on glucose and found that only
DlrpDilvB is unable to grow; however, DlrpDilvN, DlrpDilvH, and
DlrpDilvI were all capable of growing in glucose minimal media
(Figure 4A). This is consistent with earlier reports that the catalytic
subunits (ilvB and ilvI) are still active in the absence of the smaller
regulatory subunits (ilvM, ilvN and ilvH) [27]. To reconcile the
positive growth phenotype of a Dlrp mutant grown on malate,
GeneForce needed to override the regulatory rule for one of the
malate transporters in E. coli. We subsequently found that DdctA
and DlrpDdctA mutants did not grow on L-malate, while the Dlrp
mutant grew (Figure 4B) , implying that the dctA rule needed
correction.
Ribose-5-phosphate isomerase (RPI) catalyzes the reversible
conversion of ribose-5-phosphate to ribulose-5-phosphate in the
pentose phosphate pathway. Two RPIs have been identified in E.
coli, RpiA and RpiB, which are genetically and biochemically
distinct. RpiA is constitutively expressed and accounts for most of
the RPI activity in wild-type cells [28]. RpiB also functions as an
allose-6-phosphate isomerase, catalyzing the second step in the
allose degradation pathway [29]. It has been shown that rpiB
expression is repressed by a regulator, RpiR, which is located on
the same operon [30]. We subsequently measured growth of DrpiA,
DrpiB, and DrpiADrpiB mutants on D-ribose and D-allose, and
found that only the double deletion exhibited a lethal phenotype
on D-ribose (Figure 4C), while neither DrpiB nor DrpiADrpiB
Figure 2. Accuracy and Number of Rule Correction Cases.
Application of GeneForce to correct growth phenotype predictions by
overriding regulatory rules (A) Growth phenotype prediction accuracy
of integrated regulatory-metabolic network models at various steps of
regulatory network refinement. Accuracy (solid circles) is calculated by
dividing total number of correct (experimentally consistent) predictions
by the total number of cases evaluated (open squares) at each step. The
colors correspond to the metabolic networks used in the integrated
metabolic and regulatory network models with red for iJR904 and blue
for iAF1260. (B) The total number of ‘rule correction’ cases (solid circles)
for each regulatory network is plotted. Such cases are represented by +/
+/2 (Exp/Met/Met+Reg) in the growth comparison tables (Supporting
Information Table S1 and S2).
doi:10.1371/journal.pcbi.1000970.g002
Figure 3. Number of Rule Corrections Needed to Correct Model
Predictions. Distribution of rule corrections for +/+/2 cases before
and after rule corrections for (A) iJR904 with rules from iMC104 (with
Lrp modified regulatory rules) and iMC105A, and (B) iAF1260 with rules
from iMC105A and iMC105AB. The total number of +/+/2 cases for each
integrated model is indicated in parenthesis in the legend. For each +/
+/2 case the minimum number of genes requiring regulatory rule
corrections was determined. Panels A and B are histograms represent-
ing the number of cases where 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 genes
need regulatory rule corrections.
doi:10.1371/journal.pcbi.1000970.g003
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for RpiR had only D-ribose as an inducer; as a result no growth in
the D-allose medium condition was incorrectly predicted by the
integrated model. We subsequently changed the rule for rpiR to
also include D-allose as an inducer based on the study of allose
catabolism [31].
Figure 4. Phenotyping Experiments to Confirm Rule Corrections. Growth phenotype screens for (A) BW25113 (parent strain), lrp::kan DilvB,
lrp::kan DilvN, lrp::kan DilvH, and lrp::kan DilvI on glucose M9 minimal media, (B) BW25113, lrp::kan, DdctA, and lrp::kan DdctA on L-malate M9 minimal
media, (C) BW25113, DrpiA, DrpiB, and rpiA::kan DrpiB on D-ribose M9 minimal media, (D) BW25113, DrpiA, DrpiB, and rpiA::kan DrpiB on D-allose M9
minimal media, (E) BW25113, DcycA, DdsdX, and cycA::kan DdsdX on D-alanine M9 minimal media, and (F) BW25113, DcycA, DdsdX, and cycA::kan
DdsdX on D-serine M9 minimal media.
doi:10.1371/journal.pcbi.1000970.g004
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ments for cycA based on the utilization of D-alanine and D-serine.
In this case the algorithm helped lead to improvements in GPR
associations in the metabolic network as well as the regulatory rule
for cycA. The integrated model incorrectly predicted that these
compounds could not be used as carbon and nitrogen sources,
which GeneForce attributed to the expression rule for the CycA
transporter. We subsequently measured growth of DcycA, DdsdX,
and DcycADdsdX mutants, and found that the DcycA and
DcycADdsdX mutant were unable to grow with D-alanine as a
carbon source (Figure 4E) and that only the DcycADdsdX double
mutant was unable to grow with D-serine as a carbon source
(Figure 4F). This indicates that cycA is expressed under both
conditions and that dsdX is also expressed when D-serine is present
as a carbon source. The transport of D-serine by DsdX has only
been shown in an uropathogenic strain of E. coli [32] and based on
our phenotyping results this protein appears to have the same
function in BW25113 as well. As a result, the DsdX transporter
was to be added to the metabolic model and the regulatory rule for
cycA was modified. Altogether, these experimental results illustrate
how GeneForce can help identify incorrect regulatory rules or
missing metabolic functionality which cause model-data discrep-
ancies.
To investigate the effects the model corrections have in other
conditions we evaluated how many new false positives were
introduced (i.e. 2/+/2 cases became 2/+/+) for each refinement
step (Supporting Information Table S4) and whether the predicted
flux distributions would change using flux variability analysis [33].
In refinement steps A and B, the number of new false positives was
only ,7% of the total number of corrected errors. Although 17
new false positives were introduced in refinement step C to correct
53 model errors, the corrections were supported by experimental
results. Aside from the argD case described above, we did not find
any rule corrections that caused significantly more false positives
for other knockout mutant or medium conditions. We further
evaluated the effects the model changes had on predicted wildtype
optimal metabolic flux distributions. Flux variability analysis was
done before and after Refinement A with iJR904 and before and
after Refinements B+C with iAF1260. This analysis was done for
conditions in which the models predict non-zero growth rates
before and after the refinements (84 media conditions for iJR904
and 112 media conditions for iAF1260), since the model changes
were not intended to affect these conditions. We found that the
model changes had no significant effect on the predicted wildtype
fluxes for the 84 and 112 conditions examined (maximum and
minimum predicted flux values changed by less than 0.004 mmol/
gDW/hr, which corresponds to ,0.04% of the carbon source
uptake rates), except for the two conditions with L-malate and
D,L-malate as carbon sources. In these two conditions, the
regulatory rule change for dctA in Refinement C allows D-malate
to be transported and L-malate to be transported with a more
energetically efficient transporter. As a result higher growth rates
can be achieved for these two conditions and the optimal flux
distributions will change significantly.
Use of GeneForce algorithm for predicting mechanisms
for rescuing non-growth phenotypes
In addition to identifying regulatory rules that cause inconsis-
tencies between model predictions and experimental growth
phenotypes, another utility of the GeneForce algorithm is to
identify genes whose transcriptional regulation prevents cells from
growing. In this case the integrated model and regulatory rules are
correct, and the un-expressed state of certain metabolic genes
prevents the cells from utilizing a particular carbon or nitrogen
source. The algorithm functions in the same manner as before,
with the difference being that it is used in 2/+/2 cases in which
cells are incapable of growing experimentally, the metabolic model
indicates that the genes necessary to support growth are present in
the genome, but the integrated metabolic and regulatory model
correctly predicts a non-growth phenotype because the necessary
genes are not expressed. While the algorithm would falsely violate
regulatory rules in order to allow the model to achieve a non-zero
growth rate, such false violations are of interest since they indicate
which genes if over-expressed would allow for growth. Experi-
mentally, such results could be tested by increasing the expression
of the identified genes.
In our analysis of ,32,000 mutant phenotypes using
iJR904+iMC105A, we identified ten medium conditions, where
the GeneForce algorithm repeatedly identified genes whose over-
expression could enable aerobic growth of mutant (and likely wild-
type) E. coli strains. In each of these nutritional states: (i) the
majority of the E. coli knockout mutants were unable to grow, (ii)
the metabolic model incorrectly predicts growth, and (iii) the
integrated metabolic and regulatory model correctly predicts no
growth. In seven out of the ten aerobic conditions, either a single
gene or a single operon was needed to be expressed in violation of
the regulatory rules to allow for growth. This list included citT,
xylA, allC, fucO, atoDAEB, ttdAB, and nirBD, which correspond to
the different medium conditions listed in Table 3. The distribution
of the number of genes needing overexpression to rescue these
non-growth phenotypes (2/+/2) occurred in the first two
refinement steps (Supporting Information Table S1 and Support-
ing Information Table S2) is shown in Figure 5. Similar to the case
for rule corrections (Figure 3), most of the rescue non-growth cases
required over-expressing a single gene. The refinement of the
regulatory rules (listed in Table 1) slightly reduced the number of
rescue non-growth cases by ,1–10% as some cases changed from
2/+/2 to 2/+/+ (Figure 5).
We subsequently looked for experimental evidence in the
literature that would corroborate the algorithm’s predictions of
genes whose overexpression can rescue non-growth phenotypes.
We found direct evidence in support of citT, fucO and atoDAEB
rescuing the inability of wild-type E. coli to grow aerobically on
citrate, 1,2-propanediol, and butyrate, respectively [34–38]. The
citT gene encodes a citrate transporter, and Pos et al. have shown
that plasmid mediated over-expression of citT allows for aerobic
growth on citrate [34]. The 1,2-propanediol oxidoreductase
(FucO), is required for growth on 1,2-propanediol anaerobically,
but under aerobic conditions this gene is not expressed preventing
utilization of this compound. Constitutive expression of fucO leads
to an ability to grow on 1,2-propanediol aerobically [35,37]. Wild-
Table 3. Single genes or operons that are predicted to rescue
non-growth phenotypes under aerobic conditions.
Media Gene Condition
Citrate citT Carbon Source
Sucrose xylA Carbon Source
1,2 propanediol fucO Carbon Source
Butyrate atoDAEB Carbon Source
L-tartrate ttdAB Carbon Source
Allantoin allC Nitrogen Source
Nitrite nirBD Nitrogen Source
doi:10.1371/journal.pcbi.1000970.t003
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such as butyrate, and studies have shown that the constitutive
expression of atoC, an activator of the atoDAEB operon, instills the
ability to grow on butyrate [36,38].
We were unable to find direct evidence in support of allC
(allantoin) and ttrAB (L-tartrate) but these genes encode enzymes in
the catabolic pathways for these substrates. Wild-type E. coli can
utilize allantoin as a sole nitrogen source anaerobically, but not as
a sole carbon source [39]. The inability to degrade allantoin
aerobically is thought to be due to the oxygen mediated inhibition
of the regulatory gene allS, which is an activator of the allantoin
regulon containing allC [39]. It is possible that constitutive
expression of allC would allow for utilization of allantoin in an
oxic environment. Similar strategies may also be proposed for the
ttrAB operon, which is also repressed in the presence of oxygen
thereby preventing aerobic growth on L-tartrate, a substrate that
can be used anaerobically [40].
Conservation of transcriptional regulation in E. coli and
S. typhimurium
The two bacterial strains, S. typhimurium LT2 and E. coli K-12
MG1655 are closely related and both organisms have been well
studied experimentally and modeled. However, the transcriptional
regulatory network of S. typhimurium is less characterized
experimentally, than E. coli’s, and a genome-scale transcriptional
regulatory model for S. typhimurium is not available. Recently, a
metabolic network model, (iRR1083) for S. typhimurium was
published [20], and we investigated the effects of conserving the
E. coli transcriptional regulatory interactions in S. typhimurium by
superimposing the E. coli regulatory constraints on the Salmonella
metabolic network. The regulatory model iMC105A was integrat-
ed with the metabolic model iRR1083, and we evaluated whether
this chimeric model was consistent with growth phenotypes for S.
typhimurium. The expectation was that if the transcriptional
regulatory networks were highly conserved few regulatory rule
violations would be needed to correctly predict growth.
We transferred the regulatory rules in iMC105A for E. coli genes
to their orthologs in S. typhimurium, and used the GPR association
in the S. typhimurium metabolic network to constrain fluxes through
the metabolic reactions. Among the 1,083 S. typhimurium genes
included in iRR1083, 782 genes had orthologs in E. coli that were
included in iJR904 (which included a total of 904 metabolic genes).
Additionally, among the 105 E. coli transcription factors in
iMC105A, we found 86 had orthologs in S. typhimurium which
were incorporated into the chimeric model. These differences in
conservation of metabolic and regulatory genes allowed us to
transfer approximately 83% of the regulatory rules in iMC105A,
while discarding the remaining rules associated with metabolic
genes not present in S. typhimurium or regulatory rules involving
transcription factors present only in E. coli. Any metabolic ortholog
present in S. typhimurium but regulated by transcription factors
without orthologs in S. typhimurium were kept unregulated in the
chimeric model.
We applied the GeneForce algorithm to this hybrid E. coli
regulatory-S. typhimurium metabolic model and evaluated model
predictions against wild-type S. typhimurium growth phenotypes in
196 medium conditions (Supporting Information Table S5), which
resulted in a surprisingly small number of regulatory rule
violations, suggesting a highly conserved transcriptional regulatory
network between E. coli and S. typhimurium, at least for conserved
orthologs. As seen in Table 4, only a total of 18 genes (out of 505
genes with regulatory rules) needed regulatory rule corrections,
some of which (argD, rhaR and rhaS) also needed rule corrections in
subsequent refinements of the E. coli integrated model as well
(Table 2, correction list B). Thus, 15 out of the 18 genes suggested
some regulatory differences between the two species (Table 4). For
example, the prp operon was forced to be active by the algorithm
because S. typhimurium is capable of utilizing 1, 2-propanediol
aerobically while E. coli is not [41]. The prpBCDE operon of S.
typhimurium encodes enzymes that are needed for utilization of 1,2
propanediol [42]. Regulatory rules in iMC105A state that the E.
coli prp operon is induced by propionate, while for S. typhimurium,
there is evidence that this operon is induced by the coordinated
function of regulatory proteins PrpR, IHF, and RpoN, where
activation of PrpR is induced by 2-methylcitrate, a reaction
intermediate in the 1,2-propanediol utilization pathway [43,44].
Therefore, the algorithm correctly identified the prp genes as
having incorrect rules for S. typhimurium but not for E. coli.
The glnA gene (encoding glutamine synthetase) was also
identified as requiring a rule correction in S. typhimurium but not
in E. coli for growth on glucose and D-gluconate medium. This
difference is primarily attributed to differences in the GPR
association for glutamine synthetase between the two metabolic
networks, where glnA encodes a sole enzyme for glutamine
synthesis in S. typhimurium, whereas in the E. coli models an
additional isozyme YcjK can catalyze the same reaction when glnA
expression is suppressed. Recently, however the YcjK has been
Figure 5. Number of Rule Corrections Needed to Rescue Non-
Growth Phenotypes. Distribution of ‘rescue non-growth’ (2/+/2)
cases before and after rule corrections for (A) iJR904 with rules from the
iMC104 (with Lrp modified regulatory rules) and iMC105A, and (B)
iAF1260 with rules from iMC105A and iMC105AB. The number in
parenthesis in the legends indicates the total number of (2/+/2) cases
for the different integrated models. For each 2/+/2 case on the
minimum number of genes requiring regulatory rule violations was
determined. Panels a and b are histograms representing the number of
cases requiring 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 genes to be
overexpressed to rescue non-growth phenotypes.
doi:10.1371/journal.pcbi.1000970.g005
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and ammonia so the regulatory rule for glnA and GPR association
for glutamine synthetase needs to be updated in the E. coli model
as well [45]. Similarly, the focA gene encodes the sole formate
transporter in S. typhimurium but has an alternative gene focB in E.
coli, which explains why the focA regulatory rule was not
problematic in our analysis of E. coli growth phenotypes.
The initial integrated metabolic and regulatory model for S.
typhimurium, when tested against the wild-type S. typhimurium growth
phenotypic data in 196 medium conditions was 77% accurate.
The unregulated metabolic model (unregulated iRR1083) was
82% accurate against the same growth phenotyping data. After
introducing the refined rules (Table 4), the refined integrated
metabolic and regulatory model was able to achieve 83% accuracy
for this dataset, a value similar to those found in this study for
integrated models of E. coli metabolism and regulation.
Discussion
In this work we developed a new optimization-based approach,
GeneForce, for systematically refining a genome-scale transcrip-
tional regulatory model by comparing model predictions against
high-throughput growth phenotypic data. The developed ap-
proach was used to (i) refine existing transcriptional regulatory and
metabolic models of E. coli and suggest regulatory rule corrections,
(ii) explain how transcriptional regulation prevents cellular growth
in certain conditions and identify genes which can rescue non-
growth phenotypes if expressed, and (iii) construct and refine a
new integrated regulatory and metabolic model for S. typhimurium.
We showed that even well curated transcriptional regulatory
and metabolic models for E. coli [3,21,22] can be further improved
by using the developed approach. Here, cases where the integrated
model under-predicted growth (cells grew experimentally and the
metabolic model predicted growth, but the integrated model did
not predict growth) were used to improve the integrated metabolic
and regulatory model. A total of 42 model corrections (27 listed in
Table 1 and an additional 15 described in the Materials and
Methods section) were identified and when implemented they
improved the accuracy of the models by 1–8%. The improved
integrated metabolic and regulatory model predictions were found
to better predict metabolic mutant phenotypes than other
constraint-based methods using only metabolic models. When
the iAF1260 metabolic model was used, flux balance analysis
(FBA) was ,76.5% accurate and minimization of metabolic
adjustment (MOMA) [46] was ,75.6% accurate (data not shown),
while the integrated metabolic and regulatory model (iA-
F1260+iMC105ABC) was ,79.6% accurate when predictions
were made for the metabolic gene knockouts. The integration of
metabolic and regulatory network models is thus important for
being able to more accurately predict behavior of metabolic
mutants, as well as, transcription factor mutants.
In addition to fixing incorrect model predictions, we showed
that GeneForce can also be used to evaluate correct model
predictions of non-growth conditions to explain how regulation
prevents the use of particular nutrients since the needed enzymes
are encoded in the genome. We used the approach to suggest a set
of genes which if expressed can rescue non-growth phenotypes of
mutant and wildtype strains. Experimental testing of these
hypotheses would validate that particular metabolic transforma-
tions occur and could be used to engineer novel growth
phenotypes in an organism.
In addition to applying the GeneForce approach to already
developed and refined metabolic and regulatory E. coli models, we
also applied it to a new integrated model for S. typhimurium.W e
constructed an initial transcriptional regulatory model for S.
typhimurium, by transferring the regulatory network from a closely
Table 4. Regulatory rules needing correction when integrated with a S. typhimurium metabolic network.
Gene Original rule Refined Rule
prpB (ppa(e).0) (PrpR AND RpoN AND (HimA AND HimD))
prpC (ppa(e).0) (PrpR AND RpoN AND (HimA AND HimD))
prpD (ppa(e).0) (PrpR AND RpoN AND (HimA AND HimD))
prpR
b (MCITS.0)
himA
b ON
himD
b ON
fadL ((NOT (Crp OR FadR OR OmpR))) ON
fucO (((((FucR) OR (rmn(e).0)) AND (NOT (o2(e).0 ) ) )A N DC r p )O R( ( ( F u c R )O R( r m n ( e ) .0)) AND (NOT (o2(e).0)))) (fuc-L(e).0 OR rmn(e).0)
glnA (Crp AND RpoN) ON
ttdA (NOT(o2(e).0) AND (tartr-L(e).0)) (tartr-L(e).0)
ttdB (NOT(o2(e).0) AND (tartr-L(e).0)) (tartr-L(e).0)
focA (ArcA OR Fnr AND (Crp OR NOT (NarL))) ON
argD
a (NOT ArgR) (NOT ArgR) OR (arg-L(e).0)
prsA (NOT PurR) ON
guaA (NOT (PurR AND Crp)) ON
guaB (NOT (PurR AND Crp)) ON
rhaS
a (RhaR) (RhaR OR (RhaR AND Crp))
rhaR
a (rmn(e).0) (rmn(e).0 OR lyx(e).0 OR man(e))
Corrections common to E. coli and S. typhimurium.
bprpR, himA and himD were added to the regulatory network to update the regulatory rule for the prpBCD operon, and were not part of the original 505 regulatory rules
for S. typhimurium.
doi:10.1371/journal.pcbi.1000970.t004
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regulatory rules in the integrated metabolic and regulatory model
of S. typhimurium [20]. The results showed that the transcriptional
regulatory network in E. coli is highly consistent with the growth
phenotypes of S. typhimurium, indicating that the regulatory
networks in these two organisms may be highly conserved between
these two organisms. A similar observation was found previously
by Babu et al., where ,90% of E. coli regulatory interactions were
predicted to be conserved in S. typhimurium based on the presence
of orthologs of transcription factors and their target genes in S.
typhimurium [47]. While the resulting integrated model is still
consistent with observed phenotypes for S. typhimurium, additional
work is still needed to expand this initial regulatory model to
include organism-specific regulatory interactions (such as altered
regulons and regulons that are unique for S. typhimurium).
The number of available metabolic reconstructions is rapidly
increasing, which is made possible by the increased number of
genome sequences [48]. However, the development of genome-
scale transcriptional regulatory models is currently limited by the
lack of available data for most organisms. Different approaches
have been developed to model transcriptional regulatory networks
(reviewed in [10]), but a Boolean approach has been commonly
used for building genome-scale transcriptional regulatory models
due to its scalability. Integrated models of metabolism and
transcriptional regulation have been developed using a Boolean
approach for some model organisms, such as E. coli [3] and S.
cerevisiae [4], but our current understanding of transcriptional
regulation in microorganisms is still limited due to its complexity,
interconnectivity, and intrinsic noise in these networks compared
to metabolism. The GeneForce approach can be very useful for
validating and refining transcriptional regulatory models against
new experimental data, as well as for developing new regulatory
models where initial models often yield a number of predictions
that are inconsistent with experimental data. In the past, the
identification of regulatory rules causing inconsistencies between
model predictions and experimental observations was done
through a time intensive, trial and error process [3].
Other types of non-Boolean methods are needed to integrate
genome-scale metabolic and regulatory models, since Boolean
approaches cannot capture all transcriptional regulatory interac-
tions (e.g. regulation of essential genes) and gene expression and
metabolic fluxes have variable levels that cannot be reflected using
‘On/Off’ variables. Modeling methods are available to predict gene
expression levels [49], and these predictions could be used to
constrain metabolic fluxes [50–52] at a genome-scale. The
GeneForce algorithm could be easily extended to consider other
types of integrated metabolic and regulatory models as they are
developed, where the number of genes needing expression levels
higher than those predicted by the regulatory models could be
minimized. As such, the approach would still reconcile integrated
metabolic and regulatory network models with observed growth
phenotypes and suggest improvements of such models. Other
approaches have been developed for metabolic models that use
experimentally determined flux distributions as a means to refine
metabolic models [53], and the GeneForce algorithm could be
extended to compare more quantitative data including biomass
yields (where the measured yields are used to determine the
minimumgrowth ratethreshold) and measured fluxes(where model
fluxesareconstrainedtobe acertaindistancefromtheexperimental
values) as such quantitative data become available at a large-scale.
Although automated approaches for refining metabolic models
have been developed [7,9,54,55], such an approach has not been
created for integrated models of metabolism and transcriptional
regulation. The approach developed here finds a minimum set of
refinements needed to correct one case at a time. While we did not
find it to be a significant problem here, it is possible that making
model refinements to correct one case may cause a significant
number of new incorrect predictions for other cases. Approaches
that consider multiple cases simultaneously could be advanta-
geous, but they were not considered here because of the added
computational burden for considering all conditions simultaneous-
ly. The approach described here can be used to improve
transcriptional regulatory network models by accounting for how
a hypothesized regulatory network will affect metabolism and
thereby cellular behavior. We envision that predictions of cis-
regulatory networks, based on genomic analysis and/or experi-
mental data, can be translated into Boolean regulatory models that
can be rapidly refined using our developed approach. The
identified refinements can then suggest further experiments and
lead to a re-evaluation of cis-regulatory networks. By integrating
models of metabolism and regulation, phenotypic data can be
evaluated against regulatory network predictions (which is difficult
to do without a metabolic model), thereby expanding the types of
datasets (e.g. gene expression, genome sequence, and DNA-
protein interaction) that can be used to reconstruct transcriptional
regulatory networks.
Materials and Methods
Strains
The Keio collection of in-frame single-gene deletion strains [25]
and E. coli K-12 BW25113 (the parent strain of the Keio
collection) were used to confirm the model changes identified by
GeneForce. The kanamycin resistant gene (kan) was removed from
the single-deletion strains before screening mutant phenotypes in
the microplate reader (for methods see [56]). In addition, seven
double mutants (lrp::kan DilvB, lrp::kan DilvN, lrp::kan DilvH, lrp::kan
DilvI, lrp::kan DdctA, rpiA::kan DrpiB, and cycA::kan DdsdX) were
generated using P1 transduction (for methods see [57]).
Growth phenotyping experiments
Phenotype microarray (PM) experiments were conducted for
the arcA::kan, purR::kan, and lrp::kan strains from the Keio collection
using PM1 and PM2 plates following manufacturer protocols
(Biolog Inc., CA). Briefly, strains were grown on BUG+B agar
plates and resuspended in inoculating fluid containing Dye A and
loaded onto plates. Plates were incubated at 30uC and absorbance
readings were taken at 600nm at 24 and 48 hours. Other strains
were screened for growth in triplicate at 37uC in a Tecan Infinite
200 microplate reader (Tecan Group Ltd., Switzerland). Optical
density measurements at 600 nm were taken by the microplate
reader every 15 minutes. The Tecan OD measurements (ODTecan)
were converted to an OD value in a spectrophotometer with a 1cm
pathlength (OD600), using a predetermined linear relationship,
OD600=(2.566)ODTecan+0.0028. Strains were pre-cultured over-
night in 2 g/liter glucose-supplemented M9 minimal medium,
except for a few strains (listed in Figure 4A) that were evaluated for
their ability to grow on glucose which were instead pre-cultured in
LB medium. Pre-cultured cells were washed and resuspended in
media containing a new carbon source so that the starting OD (at
600 nm) was around 0.05. All carbon sources were tested in M9
minimal medium (6.8 g of Na2HPO4,3go fK H 2PO4, 0.5 g of
NaCl, 1 g of NH4Cl, 2 ml of 1M MgSO4, and 100 ml of 1 M CaCl2
per liter) supplemented with 2 g/liter of carbon source.
Data analysis
High-throughput growth phenotyping (Biolog Inc., CA) data for
E. coli from the ASAP database [18] were analyzed to assign
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conditions. In addition to the dataset (Mutant Biolog Data I)
evaluated by Covert and colleagues [3], an additional dataset
(Mutant Biolog Data II) was analyzed in this study. We considered
the phenotype microarray (PM) data for carbon (PM1 and PM2)
and nitrogen sources (PM3) that can be simulated by the
computational models, which consisted of 223 mutants in 130
conditions or 303 mutants in 153 conditions, depending on which
model was used (see below). For each PM plate, the negative
control value was subtracted from each data point (OD600), and a
cutoff parameter of 0.1 was applied to determine whether the cells
could grow (+) or not grow (2). The cutoff parameter was
obtained by separating a bimodal-like distribution of the data
(Supporting Information Figure S1), and the results were not
highly sensitive to this parameter. Another set of high-throughput
phenotyping data for single gene knockout mutants of E. coli [19]
was also used. This dataset includes growth phenotypes for 1,440
mutants in 95 environmental conditions using a GN2-MicroPlate
(Biolog Inc., CA). However, the conditions that can be simulated
by the models consist of only 102 mutants in 30 conditions or 128
mutants in 31 conditions depending on the model used, since the
majority of evaluated mutants involved knockouts of genes with
unknown function. The phenotypic data for three global
transcription factor knockout mutants (DarcA, DpurR, and Dlrp)
was generated in this study using the phenotype microarrays
(Biolog Inc., CA) as described above. In this study, we have
excluded the phenotypic data for cells grown on formate and L-
serine as carbon sources, and xanthine and xanthosine as nitrogen
sources, as they are likely false positives in the PM datasets
(formate [3]; xanthine and xanthosine [7] and L-serine (tested in
this study, data not shown) ).
Models and simulation conditions
The genome-scale models of metabolism (iJR904 [21], iAF1260
[22]) and regulation (iMC104
v1 [3]) for E. coli were integrated and
used in this study. First, regulatory interactions for the global
transcription factor, Lrp, were updated in the regulatory rules
represented in the iMC104 model based on the recent regulatory
reconstruction from analysis of gene expression and ChIP-chip
data [17]. The Lrp reconstruction categorized regulatory interac-
tions into six different modes based on the gene expression
responses of genes controlled by Lrp to exogenous leucine. We
have converted each regulatory mode into Boolean logic rules, and
updated the regulatory rules in conjunction with existing rules.
Preliminary computational analysis was performed to identify
essential genes for growth in glucose minimal media that were
predicted to be un-expressed based on the updated Lrp rules; the
regulatory rules for these seven essential genes were then changed
back to the original ones before mutant phenotypes were
evaluated. In addition, when the metabolic part of the integrated
model was replaced with the recent metabolic reconstruction,
iAF1260 instead of iJR904, another set of preliminary rule
corrections were needed for the eight genes that are essential only
in iAF1260, due primarily to changes in the biomass equation.
These fifteen preliminary rule corrections were made before the
integrated model was compared to mutant phenotypes, and thus
they are not listed in Table 1 (see Supporting Information Table
S6 for details).
Simulation conditions for the models were determined based on
the available carbon or nitrogen sources in the media as previously
described elsewhere [3] (see Supporting Information Table S7).
When testing the growth on different carbon sources, ammonia
was used as a nitrogen source and the maximum uptake rate for
ammonia was constrained to be 10 mmol/gDW/hr. Pyruvate was
used as a carbon source for testing growth on different nitrogen
sources, and its uptake rate was constrained to be 11.3 mmol/
gDW/hr. Oxygen uptake rate was constrained to be 10 mmol/
gDW/hr for all cases, and uptake rates for other essential nutrients
in each model were specified as listed in Supporting Information
Table S7.
FBA and steady-state regulatory flux balance analysis (SR-
FBA)
Flux balance analysis (FBA) [58] was performed to predict the
maximum growth rate for mutants under different conditions
using the metabolic models. In order to simulate gene deletions in
the metabolic models, we have included GPR associations where
reactions are constrained to have zero flux if an associated gene is
deleted. For the integrated metabolic and regulatory models, we
have systematically formulated an SR-FBA problem [15] with
gene knockout and transcriptional regulatory constraints [16].
Predictions were made by maximizing growth rate for each
mutant in each condition. If the maximum growth rate was
positive then the model predicted growth is designated as (+), or
otherwise designated as (2).
GeneForce formulation
GeneForce identifies the minimal set of genes that are required
for growth, but are unexpressed in a given condition due to
transcriptional regulatory constraints. In the GeneForce formula-
tion, unexpressed genes are allowed to violate the regulatory rules,
and the number of violations is minimized to prevent unnecessary
rule violations. A rule violation is implemented by introducing
surrogate gene expression indicator variables (y9g) to allow flux
through reactions whose associated genes are not expressed
according to the Boolean regulatory rules. A minimum growth
rate requirement is introduced by setting the lower bound for
growth rate to a minimum threshold value, and the threshold
value was set to 10% of the maximum growth rate predicted by
the metabolic model in this study. The algorithm was relatively
insensitive to threshold values between 5 and 50% (see Supporting
Information Table S8), because most integrated model growth rate
predictions were above 80% or below 5% of the metabolic model
predicted growth rate (see Supporting Information Figure S2).
Alternative optimal solutions were found by adding integer-cut
constraints and re-solving the problem. See Supporting Informa-
tion Text S1 for more details.
Rule correction
To identify possible regulatory rule corrections, we analyzed
the cases where the metabolic model and experimental data
agree that the mutant can grow, but the integrated model
predicts no growth (+/+/2; corresponding to experimental
data / metabolic model / integrated model). If a certain set of
regulatory rules were repeatedly violated in the GeneForce
solutions to allow for growth of a specific mutant or in a
particular medium condition, the regulatory rules for those genes
were corrected based on experimental evidence from the
literature. When alternative optimal solutions were available,
meaning that different sets of rule violations could correct the
non-growth phenotype predictions, we examined each set of
solutions and chose the most appropriate one for the specific case
based on results from additional experiments and/or information
in the literature. If a set of rule corrections caused inconsistencies
in other mutant or medium condition, such corrections were not
made unless there was strong experimental evidence for the rule
correction.
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Figure S1 Histograms of OD600 measurement in Biolog
Phenotype Microarrays (PM).
Found at: doi:10.1371/journal.pcbi.1000970.s001 (0.19 MB PDF)
Figure S2 Histograms of relative growth rate predictions by
iJR904 and iMC104 (with Lrp modified regulatory rules) for
postive and negative experimental growth phenotypes.
Found at: doi:10.1371/journal.pcbi.1000970.s002 (0.07 MB PDF)
Table S1 Phenotype-model comparison using iJR904 and
iMC104 (with Lrp modified regulatory rules).
Found at: doi:10.1371/journal.pcbi.1000970.s003 (0.51 MB XLS)
Table S2 Phenotype-model comparison using iAF1260 and
iMC105A.
Found at: doi:10.1371/journal.pcbi.1000970.s004 (0.77 MB XLS)
Table S3 Phenotype-model comparison using iAF1260 and
iMC105AB/iMC105ABC for DarcA, DpurR, and Dlrp mutants.
Found at: doi:10.1371/journal.pcbi.1000970.s005 (0.03 MB XLS)
Table S4 Detailed statistics of model-data comparisons and
alternative optimal solutions for each refinement step.
Found at: doi:10.1371/journal.pcbi.1000970.s006 (0.03 MB XLS)
Table S5 Phenotype-model comparison using iRR1083 (Salmo-
nella typhimurium LT2) and iMC105A.
Found at: doi:10.1371/journal.pcbi.1000970.s007 (0.03 MB XLS)
Table S6 Preliminary analysis for integrating the new Lrp
reconstruction and metabolic model iAF1260.
Found at: doi:10.1371/journal.pcbi.1000970.s008 (0.05 MB XLS)
Table S7 Simulation conditions for Biolog Phenotype Micro-
arrays (PM) and GN2-Microplate.
Found at: doi:10.1371/journal.pcbi.1000970.s009 (0.06 MB XLS)
Table S8 Sensitivity analysis for different values of minimum
growth rate requirement using iJR904 and iMC104 (with Lrp
modified regulatory rules).
Found at: doi:10.1371/journal.pcbi.1000970.s010 (0.03 MB XLS)
Text S1 Detailed description of the GeneForce formulation.
Found at: doi:10.1371/journal.pcbi.1000970.s011 (0.05 MB
DOC)
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